NKT Therapeutics' Unattributed VC Round

NKT Therapeutics raised a round of funding on November 10, 2007. Investors include SV Health Investors.

NKT Thereapeutics develops therapeutics based on a subset of immune cells called natural killer T cells.…

Articles about NKT Therapeutics' Unattributed VC Round: